The 20 Best Pancreatic Ductal Adenocarcinoma Doctors Near Me in Texas, US

Michael Kim is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Eugene Koay is a Radiation Oncologist practicing medicine in Houston, Texas. He has been practicing medicine for over 17 years. Dr. Koay is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Ching-wei Tzeng is a General Surgeon practicing medicine in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Shubham Pant is an Oncologist practicing medicine in Houston, Texas. Dr. Pant is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.

Daniel Von Hoff is an Oncologist practicing medicine in Dallas, Texas. Dr. Von Hoff is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Basal Cell Skin Cancer, and Agranulocytosis.

Brandon Smaglo is an Oncologist practicing medicine in Houston, Texas. Dr. Smaglo is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Colorectal Cancer, and Pancreatectomy.

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Eric Tamm is a Radiologist practicing medicine in Houston, Texas. Dr. Tamm is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, WT1-Related Wilms Tumor Syndromes, Lymphofollicular Hyperplasia, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.

Dr. Paulson is board certified in Medical Oncology and Internal Medicine. He serves as the co-director of the Gastrointestinal Research Program for The US Oncology Network, as well as the medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center.Dr. Paulson is active in clinical research focused on neuroendocrine tumors, as well as cancers of the pancreas, liver, esophagus, stomach and colon. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Gastrostomy, and Endoscopy. Dr. Paulson is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Amit Desai is a Gastroenterologist practicing medicine in Plano, Texas. Dr. Desai is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Familial Adenomatous Polyposis, Gardner Syndrome, Endoscopy, and Gastrectomy. Dr. Desai is board certified in Gastroenterology- American Board Of Internal Med/Gastroenterology and Gastroenterology- American Board Of Internal Medicine.

Naruhiko Ikoma is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Ikoma is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Gastrectomy, and Pancreaticoduodenectomy.

Layne Held is a Physician Assistant practicing medicine in Houston, Texas. Ms. Held is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma.

Dan Zhao is a Hematologist Oncology specialist and an Oncologist practicing medicine in Houston, Texas. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Acute Myelomonocytic Leukemia, Pancreatic Cancer, Familial Pancreatic Cancer, and Ampullary Cancer.

Jacqueline Weatherly is a Physician Assistant practicing medicine in Houston, Texas. Ms. Weatherly is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Gallbladder Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Ampullary Cancer, and Biliary Dyskinesia.

Herbert Zeh Iii is a General Surgeon and an Oncologist practicing medicine in Dallas, Texas. Dr. Zeh Iii is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Ampullary Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Xuchen Zhang is a Radiologist and a Neuroradiologist practicing medicine in Galveston, Texas. Dr. Zhang is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Stroke, and CAPOS Syndrome.

Laith Abushahin is an Oncologist practicing medicine in Dallas, Texas. Dr. Abushahin is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, and Pancreatectomy. Dr. Abushahin is board certified in Internal Medicine- American Board Of Internal Med, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Isaac Raijman, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Isaac Raijman specializes in Gastroenterology and works at Digestive Associates of Hou. To make an appointment, please call (713) 795-4444. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Raijman is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Choledocholithiasis, Chronic Pancreatitis, Bile Duct Obstruction, Endoscopy, and Lithotripsy. Dr. Raijman is currently accepting new patients.

Ott Le is a Radiologist practicing medicine in Houston, Texas. Dr. Le is rated as an Advanced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Pancreatic Ductal Adenocarcinoma, Lymphofollicular Hyperplasia, and Pancreatectomy.